Sorafenib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Stage III Melanoma
type: MedicalStudy
description: A Phase II Pilot Trial of Sorafenib, Tamoxifen and Cisplatin as Adjuvant Therapy for Patients With Stage III Malignant Melanoma
status: UNKNOWN
study design: INTERVENTIONAL
phase: PHASE2
start date: 2007-04
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00492505
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: San Diego Pacific Oncology & Hematology Associates
study subject: Melanoma (Skin)
keywords: PHASE2
keywords: INTERVENTIONAL
keywords: UNKNOWN
keywords: Melanoma (Skin)

AI Analytics
type: Organization